|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
University of Southern California |
| Information provided by: | NIH AIDS Clinical Trials Information Service |
| ClinicalTrials.gov Identifier: | NCT00002052 |
Purpose
To compare the effectiveness of standard treatment with parenteral ampicillin and oral amoxicillin compared to initial daily therapy with ceftriaxone followed by 3 times weekly suppressive treatment for salmonella infections in AIDS patients.
| Condition | Intervention |
|
HIV Infections Salmonella Infections |
Drug: Ceftriaxone sodium Drug: Ampicillin sodium Drug: Amoxicillin trihydrate |
| MedlinePlus related topics: | AIDS Salmonella Infections |
| ChemIDplus related topics: | Ceftriaxone Ceftriaxone Sodium Amoxicillin Amoxicillin sodium Amoxicillin trihydrate Ampicillin Ampicillin sodium Ampicillin trihydrate |
| Study Type: | Interventional |
| Study Design: | Treatment, Dose Comparison |
| Official Title: | Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Exclusion Criteria
Co-existing Condition:
Patients with the following are excluded:
Patients with the following are excluded:
Prior Medication:
Excluded within 48 hours of study entry:
HIV infection, AIDS, or AIDS related complex (ARC).
Contacts and Locations
More Information
| Study ID Numbers: | 019A |
| First Received: | November 2, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00002052 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|
|